Feelfree Gel: Each gram gel contains Lactic Acid BP 18 mg, Citric Acid BP 10 mg & Potassium Bitartrate USP 4 mg.

Feelfree is indicated for the prevention of pregnancy in female of reproductive potential for use as an on-demand method of contraception.

Administer 5 g gel Feelfree vaginally by the applicator immediately before (or up to one hour before) each episode of vaginal intercourse. May use during any part of the menstrual cycle or as directed by the physicians. 

Flutispray™ Plus: Each spray delivers Fluticasone Propionate BP 50 meg and Azelastine hydrochloride BP 137 meg.

Flutispray™ Plus is indicated for the relief of symptoms of seasonal allergic rhinitis in patients 6 years of age and older who require treatment with both Azelastine Hydrochloride and Fluticasone Propionate for symptomatic relief.

The recommended dosage of Flutispray™ Plus is one spray in each nostril twice daily.

Flutispray™ Nasal Spray: Each spray contains

Fluticasone Propionate BP 50 meg.

Flutispray™ is indicated for the management of the nasal symptoms of seasonal & perennial allergic & non-allergic rhinitis in adults and paediatric patient 4 years of age and older.

Adults 02 (two) sprays in each nostril once daily, preferably in the morning.

In some cases, 02 (two) sprays in each nostril twice daily may be required or as directed by the physician.

Total daily doses of 200 meg (04 sprays) should not generally be exceeded.

Children (4 to 11 years of age) 01 (one) spray in each nostril once daily. In some cases, 01 (one) spray in each nostril twice daily may be required or as directed by the physician.

Total daily doses of 100 meg (2 sprays) should not generally be exceeded or as directed by the physicians

Composition:

Filodox™ SR Tablet : Each sustained release tablet contains Doxofylline INN 400 mg.

Filodox™ 400 Tablet : Each film coated tablet contains Doxofylline INN 400 mg.

Filodox™ 200 Tablet : Each film coated tablet contains Doxofylline INN 200 mg.

Filodox™ 100 ml Syrup : Each 5 ml syrup contains Doxofylline INN 100 mg.

Indications:

Filodox™ (Doxofylline) is used to treat asthma, COPD and bronchospasm.

Dosage and Administration:

Elderly: 200 mg Tablet two or three times daily.

Adults: 400 mg Tablet two or three times daily or as prescribed by physician.

Children 6 years over: 6 mg/ kg body weight two or three times daily.

If daily required dose is Doxofylline 400 mg then Filodox™ SR Tablet to be taken once daily or as directed by the physician.

Flubiotic 250 Capsule: Each capsule contains flucloxacillin sodium BPequivalent to 250 mg flucloxacillin.

Flubiotic 500 Capsule: Each capsule contains flucloxacillin sodium BPequivalent to 500 mg flucloxacillin. 

Flubiotic Powder for Syrup: Each 5 ml reconstituted syrup contains flucloxacillin sodium BP equivalent to 125 mg flucloxacillin. 

Flucloxacillin is indicated for the treatment of infections due to gram positive organisms, 

(including infections caused by beta-lactamase producing staphylococci). 

Oral dosage should be administered half to one hour before meal or two hour after meal.Usual adult dose (including elderly patients): Oral 250 mg four times daily. Dosage may be 

doubled in severe infections. Osteomyelitis, endocarditis: up to 8 gm daily in divided doses (6 to 8 hourly) or as directed by the physician.

Fixcef 250 Tablet: Each film coated tablet contains Cefuroxime Axetil BP equivalent to Cefuroxime 250 mg.

Pharyngitis/tonsillitis, Acute bacterial otitis media, Acute bacterial maxillary sinusitis.

Acute bacterial exacerbations of chronic bronchitis and secondary bacterial infection of acute bronchitis, 

Uncomplicated skin and skin-structure infections, Uncomplicated urinary tract infections, 

Uncomplicated gonorrhoea (urethral and endocervical), Early lyme disease (erythema migrans).

For oral administration

Fixcef™ Plus Tablet: The usual course of therapy with Cefuroxime-Clavulanic acid tablets is 5 to 7 days for treatment of 

bronchitis and 7 to 10 days for other infections. Adolescents andAdults (13 years and older)

Pharyngitis/tonsillitis, Acute bacterial otitis media, Acute bacterial maxillary sinusitis.

Acute bacterial exacerbations of chronic bronchitis and secondary bacterial infection of acute bronchitis, Uncomplicated skin and skin-structure infections, Uncomplicated urinary tract infections, Uncomplicated gonorrhoea (urethral and endocervical), Early

lyme disease (erythema migrans).

For oral administration

Fixcef™ Plus Tablet: The usual course of therapy with Cefuroxime-Clavulanic acid tablets is 5 to 7 days for treatment of bronchitis and 7 to 10 days for other infections. Adolescents andAdults (13 years and older)